ImClone beats Street EPS

IMCL reported second quarter non-GAAP diluted EPS of $0.37, beating the Street estimate by $0.04, and up 28% from $0.29 in the same period last year. This quarter's EPS figure excludes expenses associated with discontinuing small molecule research. Company spokesperson David Pitts said analyst estimates assumed more diluted shares than IMCL has. ...